NCT00656968View on ClinicalTrials.gov

Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Helicobacter Infection
Interventions
DRUG

10-day sequential treatment

esomeprazole (40 mg daily) from day 1 to day 10, amoxicillin (1 g, bid) from day 1 to day 5, clarithromycin (500 mg, bid) from day 6 to day 10, metronidazole (500 mg, bid) from day 6 to day 10

DRUG

10-day concomitant therapy

esomeprazole (40 mg, bid) from day 1 to day 10, amoxicillin (1 g, bid) from day 1 to day 10, clarithromycin (500 mg, bid) from day 1 to day 10, metronidazole (500 mg, bid) from day 1 to day 10

Trial Locations (2)

807

Chung-Ho Hospital, Kaohsiung

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

lead

Kaohsiung Veterans General Hospital.

OTHER

NCT00656968 - Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter